Beyond Ozempic: The GLP-1 Boom
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Beyond Ozempic: The GLP-1 Boom
-
Narrated by:
-
By:
About this listen
Ozempic. Wegovy. Mounjaro. Zepbound. You’ve probably heard the name of one of these drugs in the past few years—maybe you’ve even thought about taking them. Every day, more Americans are taking these drugs known as GLP-1s, either for chronic conditions like diabetes or, increasingly, for weight loss. So do these drugs deliver on the promise of easy weight loss? And are they right for everyone? This episode, we talk with Mayo Clinic dietitian and host of Mayo Clinic On Nutrition Tara Schmidt about the drugs that have taken weight loss culture by storm.
Find us online at Mayo Clinic Press for more health and wellness articles, podcasts and books.
Do you have feedback, questions or topic suggestions? Email us at mcppodcasts@mayo.edu.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
activate_mytile_page_redirect_t1
What listeners say about Beyond Ozempic: The GLP-1 Boom
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.